• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Cytek Biosciences Set to Join S&P SmallCap 600

    4/25/23 5:54:00 PM ET
    $ABT
    $CSII
    $CTKB
    $SPGI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $ABT alert in real time by email

    NEW YORK, April 25, 2023 /PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, May 1. S&P 500 and 100 constituent Abbott Laboratories (NYSE:ABT) is acquiring Cardiovascular Systems in a deal expected to be completed soon, pending final closing conditions.

    Following is a summary of the changes that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name      

    Action

    Company Name

    Ticker

    GICS Sector

    May 1, 2023

    S&P SmallCap 600

    Addition

    Cytek Biosciences

    CTKB

    Health Care



    S&P SmallCap 600

    Deletion

    Cardiovascular Systems

    CSII

    Health Care

    For more information about S&P Dow Jones Indices, please visit www.spdji.com

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    [email protected]

    Media Inquiries

    [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/cytek-biosciences-set-to-join-sp-smallcap-600-301807529.html

    SOURCE S&P Dow Jones Indices

    Get the next $ABT alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ABT
    $CSII
    $CTKB
    $SPGI

    CompanyDatePrice TargetRatingAnalyst
    Abbott Laboratories
    $ABT
    6/16/2025$143.00Market Perform
    Leerink Partners
    Cytek Biosciences Inc.
    $CTKB
    5/9/2025$4.00Buy → Hold
    TD Cowen
    S&P Global Inc.
    $SPGI
    4/10/2025$600.00Buy
    BofA Securities
    S&P Global Inc.
    $SPGI
    3/12/2025$599.00Outperform
    Mizuho
    Cytek Biosciences Inc.
    $CTKB
    1/31/2025$7.00 → $4.50Buy → Sell
    Goldman
    S&P Global Inc.
    $SPGI
    12/20/2024$600.00Buy
    Citigroup
    Abbott Laboratories
    $ABT
    10/8/2024$130.00Outperform
    Oppenheimer
    S&P Global Inc.
    $SPGI
    10/2/2024$599.00Outperform
    Evercore ISI
    More analyst ratings

    $ABT
    $CSII
    $CTKB
    $SPGI
    SEC Filings

    See more
    • SEC Form 11-K filed by S&P Global Inc.

      11-K - S&P Global Inc. (0000064040) (Filer)

      6/25/25 6:16:08 PM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • SEC Form 8-K filed by Cytek Biosciences Inc.

      8-K - Cytek Biosciences, Inc. (0001831915) (Filer)

      6/24/25 4:05:58 PM ET
      $CTKB
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form 11-K filed by Abbott Laboratories

      11-K - ABBOTT LABORATORIES (0000001800) (Filer)

      6/20/25 4:05:52 PM ET
      $ABT
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ABT
    $CSII
    $CTKB
    $SPGI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Stratton John G

      4 - ABBOTT LABORATORIES (0000001800) (Issuer)

      7/1/25 5:32:18 PM ET
      $ABT
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Roman Michael F

      4 - ABBOTT LABORATORIES (0000001800) (Issuer)

      7/1/25 5:24:18 PM ET
      $ABT
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Gonzalez Patricia Paola

      4 - ABBOTT LABORATORIES (0000001800) (Issuer)

      7/1/25 5:13:51 PM ET
      $ABT
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ABT
    $CSII
    $CTKB
    $SPGI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • October 24, 2023 - FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes

      For Immediate Release: October 24, 2023 Today, the U.S. Food and Drug Administration approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory (R/R) myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. This is the first targeted therapy approved for this indication. The agency also approved the Abbott RealTime

      10/24/23 3:52:17 PM ET
      $ABT
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ABT
    $CSII
    $CTKB
    $SPGI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Leerink Partners initiated coverage on Abbott Labs with a new price target

      Leerink Partners initiated coverage of Abbott Labs with a rating of Market Perform and set a new price target of $143.00

      6/16/25 8:17:39 AM ET
      $ABT
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Cytek Biosciences downgraded by TD Cowen with a new price target

      TD Cowen downgraded Cytek Biosciences from Buy to Hold and set a new price target of $4.00

      5/9/25 8:41:00 AM ET
      $CTKB
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • BofA Securities resumed coverage on S&P Global with a new price target

      BofA Securities resumed coverage of S&P Global with a rating of Buy and set a new price target of $600.00

      4/10/25 8:19:38 AM ET
      $SPGI
      Finance: Consumer Services
      Finance

    $ABT
    $CSII
    $CTKB
    $SPGI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Mccombe William D. bought $97,300 worth of shares (35,000 units at $2.78), increasing direct ownership by 169% to 55,746 units (SEC Form 4)

      4 - Cytek Biosciences, Inc. (0001831915) (Issuer)

      6/3/25 5:39:17 PM ET
      $CTKB
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Director Jacoby Rebecca bought $8,971 worth of shares (69 units at $130.01), increasing direct ownership by 17% to 469 units (SEC Form 4)

      4 - S&P Global Inc. (0000064040) (Issuer)

      6/17/24 4:04:40 PM ET
      $SPGI
      Finance: Consumer Services
      Finance

    $ABT
    $CSII
    $CTKB
    $SPGI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change

      IRVINE, CA, and HERSTAL, BELGIUM – July 3, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced the appointment of Michael Holder to its Board of Directors as the Chair of the Audit Committee. Mr. Holder will take the seat of Regine Slagmulder, whose term completed in May. Mr. Holder is a highly accomplished executive with over 30 years of diverse experience, including nine board, four CEO, and five CFO roles across public and private biotech, medtech, health tech, pharma, and wellness companies. His expertise encompasses corporate strategy, M&A, corporate governance, and sales productivity. He's led a $25

      7/3/25 1:00:00 PM ET
      $CTKB
      $MDXH
      Biotechnology: Laboratory Analytical Instruments
      Industrials
      Medical Specialities
      Health Care
    • Datadog Set to Join S&P 500

      NEW YORK, July 2, 2025 /PRNewswire/ -- Datadog Inc. (NASD: DDOG) will replace Juniper Networks Inc. (NYSE:JNPR) in the S&P 500 effective prior to the opening of trading on Wednesday, July 9. S&P 500 constituent Hewlett Packard Enterprise Co. (NYSE:HPE) acquired Juniper Networks on July 2.  Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector July 9, 2025 S&P 500 Addition Datadog DDOG Information Technology July 9, 2025 S&P 500 Deletion Juniper Networks JNPR Information Technology For more information about S&P Dow Jones Indices, please visit www.spdji.com ABOUT S&

      7/2/25 5:55:00 PM ET
      $DDOG
      $HPE
      $JNPR
      $SPGI
      Computer Software: Prepackaged Software
      Technology
      Retail: Computer Software & Peripheral Equipment
      Computer Communications Equipment
    • S&P Dow Jones Indices Announces Update to S&P Composite 1500 Market Cap Guidelines

      NEW YORK, July 1, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") is updating the market capitalization eligibility criteria for additions to the S&P Composite 1500 Indices. Effective July 1, 2025, the size ranges will be updated as follows: Previous Market Capitalization Eligibility Criteria Updated Market Capitalization Eligibility Criteria Unadjusted company market capitalization of: •  US$ 20.5 billion or more for the S&P 500 •  US$ 7.4 billion to US$ 20.5 billion for the S&P    MidCap 400 •  US$ 1.1 billion to US$ 7.4 billion for the S&P    SmallCap 600 Unadjusted company market capitalization of: •  US$ 22.7 billion or more for the S&P 500 •  US$ 8.0 billion to US$ 22.7 billi

      7/1/25 5:40:00 PM ET
      $SPGI
      Finance: Consumer Services
      Finance

    $ABT
    $CSII
    $CTKB
    $SPGI
    Leadership Updates

    Live Leadership Updates

    See more
    • Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change

      IRVINE, CA, and HERSTAL, BELGIUM – July 3, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced the appointment of Michael Holder to its Board of Directors as the Chair of the Audit Committee. Mr. Holder will take the seat of Regine Slagmulder, whose term completed in May. Mr. Holder is a highly accomplished executive with over 30 years of diverse experience, including nine board, four CEO, and five CFO roles across public and private biotech, medtech, health tech, pharma, and wellness companies. His expertise encompasses corporate strategy, M&A, corporate governance, and sales productivity. He's led a $25

      7/3/25 1:00:00 PM ET
      $CTKB
      $MDXH
      Biotechnology: Laboratory Analytical Instruments
      Industrials
      Medical Specialities
      Health Care
    • Datadog Set to Join S&P 500

      NEW YORK, July 2, 2025 /PRNewswire/ -- Datadog Inc. (NASD: DDOG) will replace Juniper Networks Inc. (NYSE:JNPR) in the S&P 500 effective prior to the opening of trading on Wednesday, July 9. S&P 500 constituent Hewlett Packard Enterprise Co. (NYSE:HPE) acquired Juniper Networks on July 2.  Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector July 9, 2025 S&P 500 Addition Datadog DDOG Information Technology July 9, 2025 S&P 500 Deletion Juniper Networks JNPR Information Technology For more information about S&P Dow Jones Indices, please visit www.spdji.com ABOUT S&

      7/2/25 5:55:00 PM ET
      $DDOG
      $HPE
      $JNPR
      $SPGI
      Computer Software: Prepackaged Software
      Technology
      Retail: Computer Software & Peripheral Equipment
      Computer Communications Equipment
    • Ralliant Set to Join S&P SmallCap 600

      NEW YORK, June 25, 2025 /PRNewswire/ -- Ralliant Corp. (NYSE:RAL) will replace Wolfspeed Corp. (NYSE:WOLF) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 1. S&P 500 constituent Fortive Corp. (NYSE:FTV) is spinning off Ralliant in a transaction expected to be completed on June 30. Fortive will remain in the S&P 500 post spin-off. Wolfspeed announced its intention to file for bankruptcy on or before July 1 and is therefore no longer eligible for continued inclusion in the S&P SmallCap 600. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker

      6/25/25 6:12:00 PM ET
      $FTV
      $SPGI
      $WOLF
      Industrial Machinery/Components
      Industrials
      Finance: Consumer Services
      Finance

    $ABT
    $CSII
    $CTKB
    $SPGI
    Financials

    Live finance-specific insights

    See more
    • S&P Global Schedules Second Quarter 2025 Earnings Announcement and Conference Call for Thursday, July 31, 2025

      NEW YORK, June 26, 2025 /PRNewswire/ -- S&P Global's (NYSE:SPGI) second quarter 2025 results will be issued on Thursday, July 31, 2025 via news release at approximately 7:15 a.m. Eastern Daylight Time. The news release will be available at www.spglobal.com. Martina Cheung, President and CEO; Eric Aboaf, Chief Financial Officer; and Mark Grant, Senior Vice President, Investor Relations and Treasurer, will host a conference call and webcast at 8:30 a.m. Eastern Daylight Time on July 31, 2025 to discuss the Company's second quarter 2025 financial results. The presentation is open to all interested parties and may include forward-looking information. The presenters' slides, supplemental deck, a

      6/26/25 4:00:00 PM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • Abbott Hosts Conference Call for Second-Quarter Earnings

      ABBOTT PARK, Ill., June 26, 2025 /PRNewswire/ -- Abbott (NYSE:ABT) will announce its second-quarter 2025 financial results on Thursday, July 17, before the market opens.  The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be available later that day. About Abbott:Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medica

      6/26/25 9:00:00 AM ET
      $ABT
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • S&P 500 Q1 2025 Buybacks Set Quarterly Record at $293 Billion, Up 20.6%, Helping EPS Growth; Impact and Expenditures Expected to Decline in Q2 2025

      S&P 500 Q1 2025 buybacks were $293.5 billion, setting a quarterly record, previously held by Q1 2022's $281.0 billion expenditure (when prices were 23.9% lower), and were up 20.6% from Q4 2024's $243.2 billion and up 23.9% from Q1 2024's $236.8 billionThe 12-month March 2025 expenditure was $999.2 billion and was up 22.4% from the 12-month March 2024 expenditure of $816.5 billion Communication Services increased spending by 56.5% and Information Technology increased 25.8%, as Consumer Staples and Consumer Discretionary reduced their spending by 25.6% and 16.8%, respectively The net buyback 1% tax reduced Q1 2025 operating earnings by 0.50% and As Reported GAAP by 0.53%, as the 12-month cost

      6/25/25 9:00:00 AM ET
      $SPGI
      Finance: Consumer Services
      Finance

    $ABT
    $CSII
    $CTKB
    $SPGI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Cytek Biosciences Inc.

      SC 13G - Cytek Biosciences, Inc. (0001831915) (Subject)

      11/14/24 4:35:51 PM ET
      $CTKB
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Cytek Biosciences Inc.

      SC 13G/A - Cytek Biosciences, Inc. (0001831915) (Subject)

      11/14/24 1:42:15 PM ET
      $CTKB
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G filed by Cytek Biosciences Inc.

      SC 13G - Cytek Biosciences, Inc. (0001831915) (Subject)

      2/22/24 7:07:27 PM ET
      $CTKB
      Biotechnology: Laboratory Analytical Instruments
      Industrials